News

Tiny implants to monitor bodily functions or to provide insulin or any other drug based on immediate need would be an advancement in personalized medicine, but a problem inherent in implants is the tendency of the human immune system to recognize the device as an invader and encapsulate it, preventing the device from doing its job.
| 3 min read

Japanese pharmaceutical company Shionogi has signed an R&D partnership with six Irish Universities.
| 1 min read










